Response to Michael Wonder’s comments on the article ‘Assessment of the therapeutic value of new medicines marketed in Australia’
Springer Science and Business Media LLC -- Journal of Pharmaceutical Policy and Practice
DOI 10.1186/2052-3211-6-8
Abstract(s)